Drug Shortage Report for ADMELOG SOLOSTAR

Last updated on 2022-09-22 History
Report ID 166492
Drug Identification Number 02469871
Brand name ADMELOG SOLOSTAR
Common or Proper name ADMELOG SOLOSTAR
Company Name SANOFI-AVENTIS CANADA INC
Market Status MARKETED
Active Ingredient(s) INSULIN LISPRO
Strength(s) 100UNIT
Dosage form(s) SOLUTION
Route of administration SUBCUTANEOUS SUBCUTANEOUS
Packaging size 5 pens/box
ATC code A10AB
ATC description INSULINS AND ANALOGUES
Reason for shortage Other (Please describe in comments)
Anticipated start date 2022-08-26
Actual start date 2022-08-24
Estimated end date 2022-09-23
Actual end date 2022-09-21
Shortage status Resolved
Updated date 2022-09-22
Company comments Supply delay. The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date.
Health Canada comments
Tier 3 Status No
Company contact information email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2022-08-11 English Compare
v2 2022-08-11 French Compare
v3 2022-08-24 English Compare
v4 2022-08-24 French Compare
v5 2022-08-25 English Compare
v6 2022-09-19 English Compare
v7 2022-09-19 French Compare
v8 2022-09-21 English Compare
v9 2022-09-21 French Compare
v10 2022-09-22 English Compare

Showing 1 to 10 of 10